Literature DB >> 18728565

Angiographic patterns of Wingspan in-stent restenosis.

Felipe C Albuquerque1, Elad I Levy, Aquilla S Turk, David B Niemann, Beverly Aagaard-Kienitz, G Lee Pride, Phillip D Purdy, Babu G Welch, Henry H Woo, Peter A Rasmussen, L Nelson Hopkins, Thomas J Masaryk, Cameron G McDougall, David J Fiorella.   

Abstract

OBJECTIVE: A classification system developed to characterize in-stent restenosis (ISR) after coronary percutaneous transluminal angioplasty with stenting was modified and applied to describe the appearance and distribution of ISR occurring after Wingspan (Boston Scientific, Fremont, CA) intracranial percutaneous transluminal angioplasty with stenting.
METHODS: A prospective, intention-to-treat, multicenter registry of Wingspan treatment for symptomatic intracranial atherosclerotic disease was maintained. Clinical and angiographic follow-up results were recorded. ISR was defined as greater than 50% stenosis within or immediately adjacent (within 5 mm) to the implanted stent(s) and greater than 20% absolute luminal loss. ISR lesions were classified by angiographic pattern, location, and severity in comparison with the original lesion treated.
RESULTS: Imaging follow-up (3-15.5 months) was available for 127 intracranial stenotic lesions treated with Wingspan percutaneous transluminal angioplasty with stenting. Forty-one lesions (32.3%) developed either ISR (n = 36 [28.3%]) or complete stent occlusion (n = 5 [3.9%]) after treatment. When restenotic lesions were characterized using the modified classification system, 25 of 41 (61.0%) were focal lesions involving less than 50% of the length of the stented segment: three were Type IA (focal stenosis involving one end of the stent), 21 were Type IB (focal intrastent stenosis involving a segment completely contained within the stent), and one was Type IC (multiple noncontiguous focal stenoses). Eleven lesions (26.8%) demonstrated diffuse stenosis (>50% of the length of the stented segment): nine were Type II with diffuse intrastent stenosis (completely contained within the stent) and two were Type III with proliferative ISR (extending beyond the stented segment). Five stents were completely occluded at follow-up (Type IV). Of the 36 ISR lesions, 16 were less severe or no worse than the original lesion with respect to severity of stenosis or length of the segment involved; 20 lesions were more severe than the original lesion with respect to the segment length involved (n = 5), actual stenosis severity (n = 6), or both (n = 9). Nine of 10 supraclinoid internal carotid artery ISR lesions and nine of 13 middle cerebral artery ISR lesions were more severe than the original lesion.
CONCLUSION: Wingspan ISR typically occurs as a focal lesion. In more than half of ISR cases, the ISR lesion was more extensive than the original lesion treated in terms of lesion length or stenosis severity. Supraclinoid internal carotid artery and middle cerebral artery lesions have a propensity to develop more severe posttreatment stenosis.

Entities:  

Mesh:

Year:  2008        PMID: 18728565     DOI: 10.1227/01.NEU.0000335067.53190.A2

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  The issue of whether studies involving off-label use of new devices need to be replaced by controlled studies.

Authors:  Hans Henkes
Journal:  Neuroradiology       Date:  2010-09-04       Impact factor: 2.804

3.  Optimized intravenous Flat Detector CT for non-invasive visualization of intracranial stents: first results.

Authors:  Tobias Struffert; Stephan Kloska; Tobias Engelhorn; Yu Deuerling-Zheng; Sabine Ott; Marc Doelken; Marc Saake; Martin Köhrmann; Arnd Doerfler
Journal:  Eur Radiol       Date:  2010-08-14       Impact factor: 5.315

4.  Angiographic CT after intravenous contrast agent application: A noninvasive follow-up tool after intracranial angioplasty and stenting.

Authors:  M-N Psychogios; P Schramm; J-H Buhk; A Xyda; K Gröschel; K Jung; M Knauth
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

5.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

6.  Temporal correlation between wall shear stress and in-stent stenosis after Wingspan stent in swine model.

Authors:  M Fujimoto; H Takao; T Suzuki; Y Shobayashi; F Mayor; S Tateshima; M Yamamoto; Y Murayama; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

7.  Impact of retrievable stents on acute ischemic stroke treatment.

Authors:  C Brekenfeld; G Schroth; P Mordasini; U Fischer; M-L Mono; A Weck; M Arnold; M El-Koussy; J Gralla
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-12       Impact factor: 3.825

8.  Tandem Short-length Multi-stent Construct for Emergent Revascularization of Occlusive Long-segment Left Middle Cerebral Artery In-stent Stenosis.

Authors:  Torin W Karsonovich; Brittany R Bolt; Ajeet Gordhan
Journal:  Cureus       Date:  2020-04-15

9.  Disappearance of a small intracranial aneurysm as a result of vessel straightening and in-stent stenosis following use of an Enterprise vascular reconstruction device.

Authors:  Koichiro Takemoto; Satoshi Tateshima; Sachin Rastogi; Nestor Gonzalez; Reza Jahan; Gary Duckwiler; Fernando Vinuela
Journal:  BMJ Case Rep       Date:  2013-01-17

10.  Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency.

Authors:  Zsolt Vajda; Elina Miloslavski; Thomas Güthe; Elisabeth Schmid; Christoph Schul; Guido Albes; Hans Henkes
Journal:  Neuroradiology       Date:  2009-11-17       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.